Mutations in the PRPS1 can either result in a gain of function with increased expression, PRPS1 superactivity, or result in a loss of function with a decreased expression, DFN-2, CMTX5, and Arts syndrome. This evidence concerns the gene PRPS1 and Lethal ataxia with deafness and optic atrophy.